SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Life Sciences’ arm to launch unsecured high yield bonds

23 Sep 2016 Evaluate

Jubilant Life Sciences’ material wholly-owned subsidiary ‘Jubilant Pharma’ (JPL), has received an approval to launch a benchmark offering of unsecured high yield bonds outside India, under Regulation S of the US Securities Act. The bonds are proposed to be listed on the Singapore Exchange Securities Trading. The board of directors at its meeting held on September 23, 2016 has approved for the same.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.


Jubilant Pharmova Share Price

907.85 -3.75 (-0.41%)
20-Apr-2026 11:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.50
Dr. Reddys Lab 1237.75
Cipla 1238.15
Zydus Lifesciences 941.45
Lupin 2330.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×